April 20, 2014 12:27 PM ET


Company Overview of Apellis Pharmaceuticals, Inc.

Company Overview

Apellis Pharmaceuticals, Inc., a biotechnology company, develops therapeutics and drug delivery technologies, primarily in the areas of severe asthma and chronic obstructive pulmonary disease. It also conducts research for developing anti-inflammatory drugs to address chronic inflammatory diseases. The company was founded in 2009 and is based in Crestwood, Kentucky.

6400 Westwind Way

Suite A

Crestwood, KY 40014

United States

Founded in 2009



Key Executives for Apellis Pharmaceuticals, Inc.

Co-Founder and Chairman of The Board
Age: 40
Co-Founder and Chief Operating Officer
Co-Founder and Director of Clinical Research
Co-Founder and Program Manager
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Vyrix Pharmaceuticals, Inc. United States
Isosciences, LLC United States
ProteinTech Group Inc. United States
SignPath Pharma, Inc. United States
Triad Isotopes, Inc. United States

Recent Private Companies Transactions

Private Placement
July 30, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Apellis Pharmaceuticals, Inc., please visit www.apellis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.